Pituitary apoplexy during treatment of cystic macroprolactinomas with cabergoline
| Autor: | Cintia Marques dos Santos Silva, Giovanna Aparecida Balarini Lima, Evelyn de Oliveira Machado, Mônica R. Gadelha, Paulo Niemeyer Filho |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Adult
Male medicine.medical_specialty Pituitary gland Cabergoline Adolescent Adenoma Endocrinology Diabetes and Metabolism Infarction Antineoplastic Agents Gastroenterology Fatal Outcome Endocrinology Internal medicine medicine Humans Pituitary Neoplasms Prolactinoma Ergolines Macroprolactinoma business.industry Pituitary apoplexy Human physiology Middle Aged medicine.disease Magnetic Resonance Imaging Bromocriptine medicine.anatomical_structure Dopamine Agonists Female Tomography X-Ray Computed business Pituitary Apoplexy medicine.drug |
| Zdroj: | Pituitary. 11:287-292 |
| ISSN: | 1573-7403 1386-341X |
| DOI: | 10.1007/s11102-007-0046-6 |
| Popis: | Pituitary apoplexy is a rare and life-threatening clinical condition caused by hemorrhage and/or infarction of the pituitary gland or adenoma. Although pituitary apoplexy is usually spontaneous, it has been associated with numerous precipitating factors, such as bromocriptine use. However, reports of pituitary apoplexy during cabergoline therapy are scarce. We report three patients with cystic macroprolactinomas who developed pituitary apoplexy during cabergoline treatment. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink